Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

343 ARTÍCULOS , VIENDO DEL 286 AL 300

Advances in quantitative structure-activity relationship models of anti-Alzheimer's agents

Ambure P, Roy K.

Expert Opin Drug Discov. 2014 Jun;9(6):697-723. doi: 10.1517/17460441.2014.909404. Epub 2014 Apr 23.

[Progress of dementia medicine: Special reference to Alzheimer's disease]

Utsumi K.

Hokkaido Igaku Zasshi. 2014 May;89(1):21-3.

Potential therapeutic strategies for Alzheimer's disease targeting or beyond β-amyloid: insights from clinical trials

Jia Q, Deng Y, Qing H.

Biomed Res Int. 2014;2014:837157. doi: 10.1155/2014/837157. Epub 2014 Jul 17.

Increased CSF APPs-α levels in patients with Alzheimer disease treated with acitretin

Endres K, Fahrenholz F, Lotz J, Hiemke C, Teipel S, Lieb K, Tüscher O, Fellgiebel A.

Neurology. 2014 Nov 18;83(21):1930-5. doi: 10.1212/WNL.0000000000001017. Epub 2014 Oct 24.

A single-dose pilot trial of intranasal rapid-acting insulin in apolipoprotein E4 carriers with mild-moderate Alzheimer's disease

Rosenbloom MH, Barclay TR, Pyle M, Owens BL, Cagan AB, Anderson CP, Frey WH 2nd, Hanson LR.

CNS Drugs. 2014 Dec;28(12):1185-9. doi: 10.1007/s40263-014-0214-y.

Clearing the amyloid in Alzheimer's: progress towards earlier diagnosis and effective treatments - an update for clinicians

Asih PR, Chatterjee P, Verdile G, Gupta VB, Trengove RD, Martins RN.

Neurodegener Dis Manag. 2014;4(5):363-78. doi: 10.2217/nmt.14.29.

[Diagnosis and treatment of dementia: overview]

Furukawa K, Ishiki A, Tomita N, Arai H.

Rinsho Shinkeigaku. 2014;54(12):1171-3. doi: 10.5692/clinicalneurol.54.1171.

Vitamin E and memantine in Alzheimer's disease: clinical trial methods and baseline data

Dysken MW, Guarino PD, Vertrees JE, Asthana S, Sano M, Llorente M, Pallaki M, Love S, Schellenberg GD, McCarten JR, Malphurs J, Prieto S, Chen P, Loreck DJ, Carney S, Trapp G, Bakshi RS, Mintzer JE, Heidebrink JL, Vidal-Cardona A, Arroyo LM, Cruz AR, Kowall NW, Chopra MP, Craft S, Thielke S, Turvey CL, Woodman C, Monnell KA, Gordon K, Tomaska J, Vatassery G.

Alzheimers Dement. 2014 Jan;10(1):36-44. doi: 10.1016/j.jalz.2013.01.014. Epub 2013 Apr 11.

Impact of ambulatory physiotherapy on motor abilities of elderly subjects with Alzheimer's disease

Manckoundia P, Taroux M, Kubicki A, Mourey F.

Geriatr Gerontol Int. 2014 Jan;14(1):167-75. doi: 10.1111/ggi.12075. Epub 2013 Apr 25.

Alzheimer's disease: review of hormone therapy trials and implications for treatment and prevention after menopause

Henderson VW.

J Steroid Biochem Mol Biol. 2014 Jul;142:99-106. doi: 10.1016/j.jsbmb.2013.05.010. Epub 2013 May 28.

Psychometric evaluation of ADAS-Cog and NTB for measuring drug response

Karin A, Hannesdottir K, Jaeger J, Annas P, Segerdahl M, Karlsson P, Sjögren N, von Rosen T, Miller F.

Acta Neurol Scand. 2014 Feb;129(2):114-22. doi: 10.1111/ane.12153. Epub 2013 Jun 13.

Targeting estrogen receptors for the treatment of Alzheimer's disease

Lee JH, Jiang Y, Han DH, Shin SK, Choi WH, Lee MJ.

Mol Neurobiol. 2014 Feb;49(1):39-49. doi: 10.1007/s12035-013-8484-9. Epub 2013 Jun 16.

Targeting the mTOR signaling network for Alzheimer's disease therapy

Wang C, Yu JT, Miao D, Wu ZC, Tan MS, Tan L.

Mol Neurobiol. 2014 Feb;49(1):120-35. doi: 10.1007/s12035-013-8505-8. Epub 2013 Jul 14.

Therapeutic potential of turmeric in Alzheimer's disease: curcumin or curcuminoids?

Ahmed T, Gilani AH.

Phytother Res. 2014 Apr;28(4):517-25. doi: 10.1002/ptr.5030. Epub 2013 Jul 19.

Therapeutics of Alzheimer's disease: Past, present and future

Anand R, Gill KD, Mahdi AA.

Neuropharmacology. 2014 Jan;76 Pt A:27-50. doi: 10.1016/j.neuropharm.2013.07.004. Epub 2013 Jul 25.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias